Although a recent report predicts “an extinction event” for the CBD industry’s more than 3,000 brands—based on overcrowding of the market and the pandemic’s ongoing impact—the outlook for the luxury category looks better than ever.
A recent study examining the use of cannabis terpene formulation – NT-VRL on inflammatory conditions has had some promising results in treating cytokine storm syndrome caused by COVID-19.